cor2ed
engage checkpoint medical linkedin twitter
bg

Podcast: Treatment Intensification in mCSPC – The Nurse Perspective

Podcast: Treatment Intensification in mCSPC – The Nurse Perspective

Listen as GU oncology nurses share their views in this clinical update podcast

Listen as GU oncology nurses share their views in this clinical update podcast

Brenda Martone, Jennifer Sutton

In this podcast, oncology nurses Brenda Martone and Jennifer Sutton discuss how to use data to select the most appropriate treatments for patients with metastatic castration-sensitive prostate cancer. They also share the importance of being able to explain these clinical decisions to patients and reassure them that earlier intensive treatment can prolong overall survival without seriously impacting quality of life.

Portrait of Brenda Martone
Brenda Martone

Oncology Nurse Practitioner

Northwestern Medicine

United States (US)

Image of Jennifer Sutton
Jennifer Sutton

Director of Nursing & Administration

Carolina Urologic Research Center

United States (US)

preview next

time Podcast | open 19 min | Jun 2023

Subscribe to our podcast series on:

This programme was made for you:   your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

Clinical Takeaways

  • Treatment intensification with triplet therapy (ADT plus NHA plus docetaxel) should be the new standard of care for high-risk, high-volume, mCSPC patients who are fit for chemotherapy

  • Early treatment intensification should be considered for these patients whilst they are still well enough to tolerate intensive treatment

  • When determining which triplet regimen would be the most appropriate for your patient, it is important to consider the patient's co-morbidities, risk profile and potential drug-drug interactions

  • The nurse has a key role in communicating the benefits and risks of different triplet regimens to the patients

  • Patient education on potential side effects and early reporting of them is essential to optimise patient outcomes

 

 

This educational podcast is endorsed by 

This educational programme is supported by an Independent Medical Education Grant from Bayer

GU NURSES CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.

Other programmes of interest